Treatment for ITP should be aimed at treating and preventing bleeding episodes and improving
quality of life. Unnecessary treatment exposes patients to potentially serious treatment side
effects and can be costly, with little expectation of clinical benefit. Unless they are preparing for surgery or an invasive procedure, or have a significant additional risk factor for bleeding, ITP treatment is rarely
indicated for adult patients with platelet counts greater than 30,000/L
In patients preparing for surgery or other invasive procedures, short-term treatment may
be indicated to increase the platelet count prior to the planned intervention and during the
immediate post-operative period.